Guggenheim Capital LLC lifted its holdings in McKesson Co. (NYSE:MCK) by 8.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 465,969 shares of the company’s stock after acquiring an additional 37,177 shares during the quarter. Guggenheim Capital LLC owned 0.23% of McKesson worth $72,669,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Icon Wealth Partners LLC acquired a new stake in shares of McKesson in the fourth quarter worth $111,000. Wealthcare Advisory Partners LLC acquired a new stake in shares of McKesson in the third quarter worth $155,000. Virtue Capital Management LLC acquired a new stake in shares of McKesson in the fourth quarter worth $180,000. Focused Wealth Management Inc increased its stake in shares of McKesson by 650.0% in the fourth quarter. Focused Wealth Management Inc now owns 1,200 shares of the company’s stock worth $187,000 after acquiring an additional 1,040 shares during the period. Finally, Community Financial Services Group LLC acquired a new stake in shares of McKesson in the fourth quarter worth $204,000. Hedge funds and other institutional investors own 88.91% of the company’s stock.
Shares of McKesson Co. (NYSE:MCK) opened at $155.79 on Monday. McKesson Co. has a twelve month low of $133.82 and a twelve month high of $178.86. The stock has a market cap of $32,145.60, a price-to-earnings ratio of 12.42, a P/E/G ratio of 1.48 and a beta of 1.29. The company has a current ratio of 1.07, a quick ratio of 0.61 and a debt-to-equity ratio of 0.63.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, April 2nd. Shareholders of record on Thursday, March 1st will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.87%. The ex-dividend date is Wednesday, February 28th. McKesson’s payout ratio is 6.03%.
A number of analysts have recently weighed in on MCK shares. Deutsche Bank started coverage on shares of McKesson in a research note on Monday, December 4th. They issued a “buy” rating and a $175.00 price objective on the stock. Credit Suisse Group reiterated a “sell” rating and issued a $130.00 price objective on shares of McKesson in a research note on Friday, February 2nd. Jefferies Group upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $205.00 price objective on the stock in a research note on Wednesday, January 24th. ValuEngine lowered shares of McKesson from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $189.00 price objective on the stock in a research note on Friday, February 2nd. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and nine have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $176.74.
In other McKesson news, SVP Erin M. Lampert sold 1,413 shares of the stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $149.38, for a total transaction of $211,073.94. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Chairman John H. Hammergren sold 65,000 shares of the stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $160.00, for a total transaction of $10,400,000.00. The disclosure for this sale can be found here. Company insiders own 1.20% of the company’s stock.
WARNING: This story was published by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/03/12/mckesson-co-mck-holdings-lifted-by-guggenheim-capital-llc.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.